{"id":230,"date":"2014-01-09T06:08:02","date_gmt":"2014-01-09T14:08:02","guid":{"rendered":"http:\/\/66.147.244.209\/~canadiu3\/?p=230"},"modified":"2014-01-15T06:09:36","modified_gmt":"2014-01-15T14:09:36","slug":"drug-safety-agency-authorizes-sales-of-cannabis-based-medicine-for-the-first-time-in-france","status":"publish","type":"post","link":"https:\/\/canadianinquirer.net\/v1\/2014\/01\/09\/drug-safety-agency-authorizes-sales-of-cannabis-based-medicine-for-the-first-time-in-france\/","title":{"rendered":"Drug safety agency authorizes sales of cannabis based medicine for the first time in France"},"content":{"rendered":"<figure id=\"attachment_231\" aria-describedby=\"caption-attachment-231\" style=\"width: 251px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/66.147.244.209\/~canadiu3\/wp-content\/uploads\/2014\/01\/1229216i9v1hhwrjh1ikkf.jpg\"><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/66.147.244.209\/~canadiu3\/wp-content\/uploads\/2014\/01\/1229216i9v1hhwrjh1ikkf.jpg\" alt=\"Wikimedia Commons\" width=\"251\" height=\"201\" class=\"size-full wp-image-231\" \/><\/a><figcaption id=\"caption-attachment-231\" class=\"wp-caption-text\">Wikimedia Commons<\/figcaption><\/figure>\n<p>PARIS\u2014The French drug safety agency has approved commercial sales of a medicine derived from cannabis for the first time in France.<\/p>\n<p>France\u2019s Health Ministry said in a statement Wednesday that sales of Sativex, produced by Britain\u2019s GW Pharmaceuticals, will be allowed for the treatment of muscle spasms associated with multiple sclerosis.<\/p>\n<p>Sativex contains marijuana\u2019s two best known components\u2014delta 9-THC and cannabidiol. The company\u2019s website says the medicine has already been launched in 11 countries and approved in more than a dozen others.<\/p>\n<p>A number of countries have been easing curbs on the sale of cannabis-based products for medical use in recent years, and the U.S. state of Colorado allowed the nation\u2019s first legal recreational marijuana shops to open starting this year.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>PARIS\u2014The French drug safety agency has approved commercial sales of a medicine derived from cannabis for the first time in &hellip;<\/p>\n","protected":false},"author":44,"featured_media":231,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[37],"tags":[],"class_list":["post-230","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","mauthors-the-associated-press"],"_links":{"self":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/230","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/users\/44"}],"replies":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/comments?post=230"}],"version-history":[{"count":0,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/230\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media\/231"}],"wp:attachment":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media?parent=230"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/categories?post=230"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/tags?post=230"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}